Use of whey permeate for the treatment of metabolic syndrome

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 35/20 (2006.01) A61P 3/10 (2006.01) A61P 9/00 (2006.01) A61P 9/12 (2006.01)

Patent

CA 2532833

The invention relates to the use of whey permeate, preferably sweet whey permeate and more preferably hydrolysed or partially-hydrolysed sweet whey permeate for the production of a pharmaceutical composition for prophylaxis or treatment of symptoms of metabolic syndrome, type-2 diabetes and secondary diseases, said composition being provided for a mammal.

L'invention concerne un perméat de lactosérum, de préférence, un perméat de lactosérum doux, idéalement un perméat de lactosérum doux hydrolysé ou partiellement hydrolysé utilisé pour produire une composition pharmaceutique destinée à la prévention ou au traitement des symptômes du syndrome métabolique, du diabète de type 2 et de leurs maladies consécutives chez un nourrisson.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of whey permeate for the treatment of metabolic syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of whey permeate for the treatment of metabolic syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of whey permeate for the treatment of metabolic syndrome will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1798369

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.